CME webinar: Xylazine-Associated Wounds: Considerations for Antimicrobial Stewardship and Wound Care

Dec. 2024Education/Webinars

Please join us for a live, CME-accredited webinar on Tuesday, Feb. 25, from noon to 1 p.m. that will educate providers on the important topic of xylazine associated wounds.

At the end of this learning session, you will be able to:

  • Discuss antimicrobial stewardship program adaptations for people who inject drugs.
  • Identify outpatient antimicrobial treatment considerations for xylazine-associated wounds.
  • Review pharmacology and treatment of xylazine toxicity and withdrawal.


Presenters:

    • Michael Lynch, MD, FACMT, UPMC Health Plan Quality and Substance Use Disorder Services Senior Medical Director; Director, UPMC Medical Toxicology Telemedicine Bridge Clinic; Associate Professor, Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh School of Medicine

Amanda Hoyer, MPH,

    Epidemiology Research Associate, Division of Healthcare Associated Infection Prevention, Bureau of Epidemiology, Pennsylvania Department of Health

Register now. This webinar will be recorded.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team. The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. The maximum number of hours awarded for this Continuing Pharmacy Education activity is 1.0 contact hour. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.


Recent Announcements

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates

Voluntary nationwide recall: Dextrose (Baxter – August 2026)

Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.
Sep. 2026Pharmacy Updates